Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study

BACKGROUND: In patients with chronic kidney disease, metabolic syndrome has been demonstrated to be the culprit behind diverse complications. Adiponectin is known to have anti-atherogenic and cardio-protective effects. Meanwhile, the relationship between adiponectin and metabolic syndrome in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Chang-Yun, Kim, Yung Ly, Han, Seung Hyeok, Yoo, Tae-Hyun, Sung, Su-Ah, Chung, Woo-kyung, Chae, Dong-Wan, Kim, Yong-Soo, Ahn, Curie, Choi, Kyu Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109641/
https://www.ncbi.nlm.nih.gov/pubmed/27895721
http://dx.doi.org/10.1186/s13098-016-0191-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109641/
https://www.ncbi.nlm.nih.gov/pubmed/27895721
http://dx.doi.org/10.1186/s13098-016-0191-z

Ejemplares similares